1. Week 5
MPharmacy
Referencing
1

2. List of references format (book)
BOOK
1 AUTHOR
BOOK
2 AUTHORS
BOOK
MORE THAN 2 AUTHORS
EDITED BOOK
1 EDITOR
EDITED BOOK
2 EDITORS (no inf)
EDITED BOOK
MORE THAN 2 EDITORS
CHAPTER IN EDITED BOOK

3. List of references format (official
publication)
Official publication
CORPORATE AUTHOR/ORGANIZATION OFFICIAL
PUBLICATION-COMMAND PAPER

4. List of references format (journal)
JOURNAL ARTICLE
1 AUTHOR
JOURNAL ARTICLE
2 AUTHORS
JOURNAL ARTICLE
3 OR MORE AUTHORS
SAME
E-ONLY JOURNAL ARTICLE
1 AUTHOR
E-ONLY JOURNAL ARTICLE
2 AUTHORS
E-ONLY JOURNAL ARTICLE
3 OR MORE AUTHORS

5. List of references format (reference
work)
REFERENCE WORK-
AUTHORED SECTION

6. List of references format (web
page)
WEB PAGE
WITH AUTHOR
WEB PAGE
NO AUTHOR

7. Suggested differences between BOOK 1 AUTHOR
and JOURNAL ARTICLE 1 AUTHOR
• Journal has title of article and title of journal. Only the
title of the journal is in italics
• Journal has comma after title of journal
• Journal has volume number
• Journal has issue number in brackets
• Journal has page numbers
• Journal does not have publisher or place

8. Agreement between in-text
references and list of references
• Erythropoietin is a hormone that is naturally produced by the
kidneys. It is used in sport to improve performance (Dobson
and Kell 2008). It is administered by being injected under the
skin, in order to stimulate red blood cell production. By
increasing the number of red blood cells, more oxygen can be
delivered to the muscles. This helps to delay fatigue so the
athlete can perform for a longer period of time at a greater
intensity (does not correspond with the list of references). As
the hormone causes the blood to thicken, the side effects of
erythropoietin are blood clots, heart attacks and strokes. If
erythropoietin is overused, there is a risk of the heart
stopping when the body slows down, for example when
sleeping (eMolecules 2011).

9. Getting it all in order
Put the following information in the
correct order:
Book
1. Smith and Williams' introduction to the principles
of drug design and action.
2. CRC.
3. 4th ed.
4. Smith, H.J. (ed.)
5. (2006)
6. Boca Raton:
9

10. Did you get it right?
Smith, H.J. (ed.) (2006) Smith and Williams'
introduction to the principles of drug design
and action. 4th ed. Boca Raton: CRC.
Look closely at the punctuation and
italics.
Smith, H.J. (ed.) (2006). Smith and Williams'
introduction to the principles of drug design
and action. 4th ed. Boca Raton: CRC.
10

11. Put the correct punctuation into the
reference below:
Book
Florence A T 2006 Physicochemical
principles of pharmacy 4th ed London
Pharmaceutical Press
11

12. Check your answer
Florence, A. T. (2006). Physicochemical
principles of pharmacy. 4th ed. London:
Pharmaceutical Press.
12

13. Getting it all in order
Put the following information in the
correct order:
Journal
1. 14 (12), 1697-704.
2. Annals of Oncology,
3. Jones, A.
4. Combining trastuzumab (Herceptin) with
hormonal therapy in breast cancer: what can be
expected and why?
5. (2003)
13

14. Did you get it right?
Jones, A. (2003). Combining trastuzumab
(Herceptin) with hormonal therapy in breast
cancer: what can be expected and why?
Annals of Oncology, 14(12), 1697-704.
Hmm … thought not.
Look closely at the punctuation and
italics.
Jones, A. (2003). Combining trastuzumab
(Herceptin) with hormonal therapy in breast
cancer: what can be expected and why?
Annals of Oncology, 14(12), 1697-704.
14

15. Put the correct punctuation into the
reference below:
Journal article, 3 or more authors
Thiam R Fournier L S Trinquart L Medioni
J Chatellier G Balvay D (2010) Optimizing
the size variation threshold for the CT
evaluation of response in metastatic renal
cell carcinoma treated with sunitinib
Annals of Oncology 21 5 936 41
15

16. Check your answer
Thiam, R., Fournier, L. S., Trinquart, L.,
Medioni, J., Chatellier, G., Balvay, D.
(2010). Optimizing the size variation
threshold for the CT evaluation of
response in metastatic renal cell
carcinoma treated with sunitinib. Annals of
Oncology, 21(5), 936-41.
16